Our results demonstrate that patients with mutations in BBS10 have significantly higher levels of C-peptide indicating insulin resistance, supporting the suggestion that they are at higher risk of cardiovascular disease than patients with mutations in BBS1. Here, BBS10 is linked to Insulin resistance.